This effect is thought to be due to its ability to slow down stomach emptying, increase feelings of fullness, and reduce appetite
Unlike many short signaling peptides that rapidly degrade in biological systems, BPC-157 exhibits relatively high structural stability and resistance to proteolytic breakdown
Growth hormone released in response to sermorelin then triggers hepatic production of IGF-1 (insulin-like growth factor 1), which mediates most of growth hormone's anabolic effects: increased lipolysis, enhanced protein synthesis, improved bone density, and tissue repair
These symptoms may be more noticeable when treatment begins or when the dose changes
Subsequently, from the previously filtered pathways, three types of pathways were then identified